Crisis and the independence of public health policies. SESPAS report 2014;Crisis e independencia de las políticas de salud pública. Informe SESPAS 2014

Gaceta Sanitaria

Volumn 28, Issue S1, 2014, Pages 24-30

  Hernández Aguado, Ildefonso ^a,b   Lumbreras Lacarra, Blanca ^a,b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Corporations; Economic crisis; Independence; Public health

Indexed keywords

ECONOMIC RECESSION; HEALTH CARE POLICY; HUMAN; PUBLIC HEALTH; SPAIN;

ECONOMIC RECESSION; HEALTH POLICY; HUMANS; PUBLIC HEALTH; SPAIN;

EID: 84901500274     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1016/j.gaceta.2014.03.005     Document Type: Short Survey

References (58)

1. Hasting G. Why corporate power is a public health priority. BMJ. 2012, 345:e5124.
2. Villoria M. Crisi conómica, globalització i corrupció. Revista del Centre d'Estudis Jordi Pujol. 2009;9:83-95. (Consultado el 10/09/2013.) Disponible en: http://www.jordipujol.cat/files/articles/MVilloria.pdf.
3. Carpenter D, Moss D, editores. Preventing regulatory capture: special interest influence and how to limit it. The Tobin Project, 2013. (Consultado el 30/08/2013.) Disponible en: http://www.tobinproject.org/books-papers/preventing-capture.
4. Michaels D. Doubt is their product: how industry's assault on science threatens your health 2008, Oxford University Press, Oxford.
5. Stuckler D., Nestle M. Big food, food systems, and global health. PloS Med. 2012, 9:e1001242.
6. Hernández-Aguado I. The tobacco ban in Spain: how it happened, a vision from inside the government. J Epidemiol Community Health. 2013, 67:542-543.
7. Labonté R., Mohindra K., Schrecker T. The growing impact of globalization for health and public health practice. Annu Rev Public Health. 2011, 32:263-283.
8. Wiist W. The corporate playbook, health, and democracy: the snack food and beverage industry industry's tactics in context. En: Stuckler D, Siegel K, editores. Oxford: Oxford University Press; 2011.
9. Brezis M., Wiist W.H. Vulnerability of health to market forces. Med Care. 2011, 49:232-239.
10. Lesser L.I., Ebbeling C.B., Goozner M., et al. Relationship between funding source and conclusion among nutrition-related scientific articles. PloS Med. 2007, 4:e5.
11. Barnes D.E., Bero L.A. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998, 279:1566-1570.
12. Kassirer J.P. On the take: how America's complicity with big business can endanger your health 2005, 42-44. Oxford University Press, New York.
13. Grüning T., Gilmore A.B., McKee M. Tobacco industry influence on science and scientists in Germany. Am J Public Health. 2006, 96:20-32.
14. Blumenthal D., Campbell E.G., Anderson M.S., et al. Withholding research results in academic life science. Evidence from a national survey of faculty. JAMA. 1997, 277:1224-1228.
15. Steinbrook R. Future directions in industry funding of continuing medical education. Arch Intern Med. 2011, 171:257-258.
16. Brussels Sunshine Lifting the veil of EU lobbying secrecy. (Consultado el 23/09/2013.) Disponible en: http://blog.brusselssunshine.eu/2010/06/high-time-for-ciaa-to-come-clean-on-its.html.
17. Royo-Bordonada MA. Is the food industry in the driver's seat? Eur J Public Health, 2013. E-letter. (Consultado el 23/09/2013.) Disponible en: http://eurpub.oxfordjournals.org/forum/topic/eurpub_el%3b404.
18. Neltner TG, Alger HM, O'Reilly JT, et al. Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance. JAMA Intern Med. 2013; Aug 7. Doi: 10.1001/jamainternmed.2013.10559.
19. Intervención de María Concepció Tarruella Tomàs. Diario de sesiones del Congreso de los Diputados. Comisión de Sanidad, Política Social y Consumo. Sesión núm. 25, 16/12/2009. Sanidad, política social y consumo. (Consultado el 23/09/2013.) Disponible en:. http://www.congreso.es/portal/page/portal/Congreso/PopUpCGI%3FCMD=VERLST%26BASE=puw9%26DOCS=1-1%26FMT=PUWTXDTS.fmt%26QUERY=%28CDC200912160450.CODI.%29%23%28P%C3%A1gina19%29.
20. Corporate Europe Observatory. Exposing the power of corporate lobbying in the EU. European Parliament postpones EFSA budget approval over conflicts of interest. (Consultado el 23/09/2013.) Disponible en: http://corporateeurope.org/pressreleases/2012/european-parliament-postpones-efsa-budget-approval-over-conflicts-interest.
21. Robinson C., Holland N., Leloup D., et al. Conflicts of interest at the European Food Safety Authority erode public confidence. J Epidemiol Community Health. 2013, 67:717-720.
22. Eaton J, Pell MB, Mehta A. Washington lobbying giants cash in on health reform debate. Center for Public Integrity, 2010, 26 de marzo. (Consultado el 23/09/2013.) Disponible en: www.publicintegrity.org/articles/entry/2010/.
23. People's Health Movement, Medact, Health Action International, Medicos International and Third World Network. World Health Organisation: captive to conflicting interests. En: Global Health Watch 3. An alternative world health report. London: Zed Books Ltd; 2011. pp. 229-48. (Consultado el 23/09/2013.) Disponible en: http://www.ghwatch.org/ghw3.
24. Tesler L.E., Malone R.E. Corporate philanthropy, lobbying, and public health policy. Am J Public Health. 2008, 98:2123-2133.
25. Nestle Arie S. PepsiCo will give nutritional advice to women in anti-hunger campaign in Mexico. BMJ. 2013, 346:f2458.
26. Mindell J.S., Reynolds L., Cohen D.L., et al. All in this together: the corporate capture of public health. BMJ. 2012, 345:e8082.
27. Fallin A., Grana R., Glantz S.A. 'To quarterback behind the scenes, third-party efforts': the tobacco industry and the Tea Party. Tob Control. 2013, en prensa.
28. Angell M. La verdad acerca de la industria farmacéutica 2006, Editorial Norma, Barcelona.
29. Knai C., Gilmore A., Lock K., et al. Public health research funding: independence is important. Lancet. 2010, 376:75-77.
30. Chokshi D.A., Farley T.A. The cost-effectiveness of environmental approaches to disease prevention. N Engl J Med. 2012, 367:295-297.
31. Kwak J. Cultural capture and the financial crisis. En: Carpenter D, Moss D, editores. Preventing regulatory capture: special interest influence and how to limit it. The Tobin Project, 2013. (Consultado el 30/08/2013.) Disponible en: http://www.tobinproject.org/sites/tobinproject.org/files/assets/Kwak%20Cultural%20Capture%20%281.16.13%29.pdf.
32. People's Health Movement, Medact, Health Action International, Medicos International and Third World Network. Conflicts of interest within philanthrocapitalism. En: Global Health Watch 3. An alternative world health report. London: Zed Books Ltd; 2011. pp. 267-74. (Consultado el 23/09/2013.) Disponible en: http://www.ghwatch.org/ghw3.
33. Powell C. The pain in Spain: political, social and foreign policy implications of the European economic crisis. Madrid: Real Instituto Elcano; 2012. (Consultado el 23/09/2013.) Disponible en: http://www.realinstitutoelcano.org/wps/wcm/connect/a5a0e3804df9df23869dbeb58c6e4bde/Powell_Pain_Spain_Europe_Trouble_oct12.pdf?MOD=AJPERES&CACHEID=a5a0e3804df9df23869dbeb58c6e4bde.
34. Corporate Europe Observatory. Lobby planet, Brussels' EU quarter. Brussels: Corporate Europe Observatory, 2011. (Consultado el 20/09/2013.) Disponible en: http://corporateeurope.org/sites/default/files/publications/ceolobbylow.pdf.
35. Tesler L.E., Malone R.E. Our reach is wide by any corporate standard: how the tobacco industry helped defeat the Clinton health plan and why it matters now. Am J Public Health. 2010, 100:1174-1188.
36. Jenkin J., Signal L., Thomson G. Framing obesity: the framing contest between industry and public health at the New Zealand inquiry into obesity. Obes Rev. 2011, 12:1022-1030.
37. Gilmore A.B., Savell E., Collin J. Public health, corporations and the new responsibility deal: promoting partnerships with vectors of disease?. J Public Health (Oxf) 2011, 33:2-4.
38. Oshaug A. What is the food and drink industry doing in nutrition conferences. Public Health Nutr. 2009, 12:1019-1020.
39. Descripción del programa Healthy Way to Grow establecido por la American Heart Association. (Consultado el 24/02/2014.) Disponible en: http://www.healthywaytogrow.org/HWTG/index.jsp.
40. Página web de la empresa Subway Eat Fresh. (Consultado el 24/02/2014.) Disponible en: http://www.kintera.org/site/c.dkLRKbOWLjK4E/b.8180513/k.BD61/Home.htm.
41. Ruano, A. El conflicto de intereses económico de las asociaciones profesionales sanitarias con la industria sanitaria. Barcelona: SESPAS; 2011. (Consultado el 23/09/2013.) Disponible en: http://www.sespas.es/adminweb/uploads/docs/Conflicto_de_Intereses.pdf.
42. Ética y salud pública. Cuadernos de la Fundació Víctor Grífols i Lucas N° 27. 2012. (Consultado el 23/09/2013.) Disponible en: http://www.sespas.es/adminweb/uploads/docs/cuaderno27X.pdf.
43. McKeown R.E., Weed D.L., Kahn J.P., et al. American College of Epidemiology Ethics Guidelines: foundations and dissemination. Sci Eng Ethics. 2003, 9:207-214.
44. Langley C, Parkinson S. Science and the corporate agenda: the detrimental effects of commercial influence on science and technology. Oct 12, 2009. (Consultado el 19/09/2013.) Disponible en: http://www.statewatch.org/news/2009/oct/scientists-for-global-responsibillty-report.pdf.
45. Tereskerz P.M., Hamric A.B., Guterbock T.M., et al. Prevalence of industry support and its relationship to research integrity. Account Res. 2009, 2:78-105.
46. Executive Board of the American Public Health Association. APHA policy for advertisers and exhibitors. 2001. (Consultado el 24/09/2013.) Disponible en: http://www.apha.org/NR/rdonlyres/85DFEDFE-9D56-44C3-ABA1-FCB31E169B4E/0/APHAAdvertisingPolicy.pdf.
47. Executive Board of the American Public Health Association. Guidelines for gifts and donations. American Public Health Association. 2001. (Consultado el 24/09/2013.) Disponible en: http://www.apha.org/NR/rdonlyres/BDF244A9-19AD-4DD4-9069-853F890EDC86/0/CSRGuidelinesforGifts2006final.pdf.
48. World Health Organization. Global strategy on diet, physical activity, and health. Report No. WHA57.17. Geneva: WHO; 2004. (Consultado el 20/09/2013.) Disponible en: http://www.who.int/gb/ebwha/pdf_files/WHA57/A57_R17-en.pdf.
49. Yoon S., Lam T.H. The illusion of righteousness: corporate social responsibility practices of the alcohol industry. BMC Public Health. 2013, 13:630.
50. Scottish Health Action on Alcohol Problems. The (ir)responsibility deal? Public health. (Consultado el 24/09/2013.) Disponible en: http://www.shaap.org.uk/UserFiles/File/shaap_the_irresponsibility_deal_public_health_and_big_busin.pdf.
51. Lang T, Rayner G, Kaelin E. The food industry, diet, physical activity and health: a review of report commitments and practice of 25 of the world's largest food companies. Centre for Food Policy, London City University. 2006. (Consultado el 24/09/2013.) Disponible en: http://archive.oxha.org/knowledge/publications/lang_foodindustry_april2006.pdf.
52. Nutrition and business. How to engage?. SCN News. 2011, 3:9. United Nations System Standing Committee on Nutrition, (Consultado el 24/09/2013.) Disponible en: http://www.unscn.org/files/Publications/SCN_News/SCNNEWS39_10.01_low_def.pdf.
53. Progress in preventing childhood obesity: how do we measure up? 2007, Institute of Medicine, The National Academies Press, Washington, DC.
54. Building public-private partnerships in food and nutrition: workshop summary 2012, Institute of Medicine, The National Academies Press, Washington, DC.
55. Victorian Health Promotion Foundation. The partnerships analysis tool for partners in health promotion. Australia, 2008. (Consultado el 24/09/2013.) Disponible en: http://www.vichealth.vic.gov.au/media/ResourceCentre/PublicationsandResources/General/VHP%20part%20toollow%20res.ashx.
56. Kraak V.I., Story M. A public health perspective on healthy lifestyles and public-private partnerships for global childhood obesity prevention. J Am Diet Assoc. 2010, 110:192-200.
57. Royo-Bordonada M.A., Martínez-Huedo M.A. Evaluation of compliance with the self-regulation agreement of the food and drink vending machine sector in primary schools in Madrid, Spain, in 2008. Gac Sanit. 2014, 28:65-68.
58. Barr D.A. Ethics in public health research: a research protocol to evaluate the effectiveness of public-private partnerships as a means to improve health and welfare systems worldwide. Am J Public Health. 2007, 97:19-25.